Captor Therapeutics (WAR:CTX) COGS-to-Revenue : 0.66 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics COGS-to-Revenue?

Captor Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2023 was zł4.27 Mil. Its Revenue for the three months ended in Dec. 2023 was zł6.49 Mil.

Captor Therapeutics's COGS to Revenue for the three months ended in Dec. 2023 was 0.66.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Captor Therapeutics's Gross Margin % for the three months ended in Dec. 2023 was 34.17%.

Captor Therapeutics COGS-to-Revenue Historical Data

The historical data trend for Captor Therapeutics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics COGS-to-Revenue Chart

Captor Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.19

0.23

0.48

Captor Therapeutics Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial														0.16	0.28	-0.07	0.63	0.66

Captor Therapeutics COGS-to-Revenue Calculation

Captor Therapeutics's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6.3	/	13.201
	=	0.48

Captor Therapeutics's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.269	/	6.485
	=	0.66

Captor Therapeutics (WAR:CTX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Captor Therapeutics's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4.269 / 6.485
	=	34.17 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Captor Therapeutics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Captor Therapeutics (WAR:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

60Q:Germany

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.captortherapeutics.com

Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics (WAR:CTX) Headlines

No Headlines